Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
X-linked intellectual disability-ataxia-apraxia syndrome is characterized by ataxia, apraxia, intellectual deficit and/or seizures. It has been described in nine males in two unrelated Danish families. It is transmitted as an X-linked recessive syndrome with partial clinical expression in obligate female carriers.
Features include very common findings: Ataxia, Mild intellectual disability, and Apraxia; and common findings: Seizure and Talipes equinovarus.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 3 | Seizure, Ataxia, Mild intellectual disability |
Biomarker and diagnostic research for X-linked intellectual disability-ataxia-apraxia syndrome has been reported in the published literature.
Phenotype severity distribution: 3 very common features, 2 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for X-linked intellectual disability-ataxia-apraxia syndrome.
208 publications have been identified in PubMed for X-linked intellectual disability-ataxia-apraxia syndrome. Research spans Case Report / Case Series (34%), Basic Science / Preclinical (31%), and Review / Meta-Analysis (20%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 71 | 34% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 6:23 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about X-linked intellectual disability-ataxia-apraxia syndrome
Laboratory research |
64 |
31% |
Research summaries | 42 | 20% |
Disease patterns and progression | 16 | 8% |
Testing and diagnosis research | 8 | 4% |
New treatment approaches | 4 | 2% |
Clinical study results | 3 | 1% |
Singin B (2026). [PMID: 40103355](https://pubmed.ncbi.nlm.nih.gov/40103355/). *J Clin Res Pediatr Endocrinol*. [Review / Meta-Analysis]
Liang Q (2026). [PMID: 41198829](https://pubmed.ncbi.nlm.nih.gov/41198829/). *J Hum Genet*. [Diagnostic / Biomarker]
Oktay MA (2026). [PMID: 42112678](https://pubmed.ncbi.nlm.nih.gov/42112678/). *J Pediatr Endocrinol Metab*. [Case Report / Case Series]
Bruschi F (2026). [PMID: 41144879](https://pubmed.ncbi.nlm.nih.gov/41144879/). *Mov Disord*. [Case Report / Case Series]
Sidorina A (2026). [PMID: 41429203](https://pubmed.ncbi.nlm.nih.gov/41429203/). *J Lipid Res*. [Diagnostic / Biomarker]
Proteau-Lemieux M (2026). [PMID: 41657078](https://pubmed.ncbi.nlm.nih.gov/41657078/). *Autism Res*. [Basic Science / Preclinical]
Rabin R (2026). [PMID: 41531333](https://pubmed.ncbi.nlm.nih.gov/41531333/). *Am J Med Genet A*. [Case Report / Case Series]
VanSickle EA (2026). [PMID: 41410504](https://pubmed.ncbi.nlm.nih.gov/41410504/). *Am J Med Genet A*. [Review / Meta-Analysis]
Zhao Y (2026). [PMID: 41705901](https://pubmed.ncbi.nlm.nih.gov/41705901/). *Prenat Diagn*. [Review / Meta-Analysis]
Liao B (2026). [PMID: 41743791](https://pubmed.ncbi.nlm.nih.gov/41743791/). *Front Mol Neurosci*. [Basic Science / Preclinical]